C
C. D. Howe
Researcher at University of Texas at Austin
Publications - 20
Citations - 656
C. D. Howe is an academic researcher from University of Texas at Austin. The author has contributed to research in topics: Virus & Oncovirus. The author has an hindex of 13, co-authored 20 publications receiving 649 citations. Previous affiliations of C. D. Howe include Texas Medical Center.
Papers
More filters
Journal ArticleDOI
Melphalan therapy for plasma cell myeloma.
TL;DR: Of 82 patients with plasma cell myeloma treated with melphalan, 40 (49 per cent) were improved in clinical status and in a direct manifestation of disease, thus supporting the usefulness of these parameters in confirming clinical response.
Journal ArticleDOI
Vinblastine in the management of testicular cancer.
Melvin L. Samuels,C. D. Howe +1 more
TL;DR: The activity of vinblastine alone and in combination with melphalan was studied in 32 patients with metastatic testicular neoplasia of germinal origin this article.
Journal ArticleDOI
Viruses and mycoplasma (PPLO) in human leukemia.
Leon Dmochowski,H. Grant Taylor,Clifford E. Grey,Donald A. Dreyer,J. A. Sykes,Phil L. Langford,Tom Rogers,C. C. Shullenberger,C. D. Howe +8 more
Journal ArticleDOI
Enlargement of the supraclavicular lymph nodes as the initial sign of prostatic carcinoma.
TL;DR: The disease should, therefore, be considered when metastatic adenocarcinoma is discovered in the supraclavicular lymph nodes, usually those on the left, of men over 45 years of age.
Journal ArticleDOI
Medroxyprogesterone acetate in the treatment of renal cell carcinoma (hypernephroma).
TL;DR: Medroxyprogesterone acetate, a potent synthetic progestational steroid, was administered to 23 patients with metastatic renal cell carcinoma and results are superior to those obtained with chemotherapy.